Latest autoimmune diseases News

European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
Nightmares could be an early warning sign of an autoimmune disease flare-up – new study
Nightmares could be an early warning sign of autoimmune disease flare-up – new study
Unlocking the body’s defences: understanding immunotherapy
Common Type Of Fiber May Trigger Bowel Inflammation
Immutep appoints research institute to conduct first-in-human study of IMP761
To Arrest Illness At Early Stage
Hope For Treating Autoimmune Diseases
New research investigates the genetics of circulating vitamin A
Rare Disease Provides Broader Knowledge
Digital Twin Allows For Tailored Medication
Cleaning – Not To Be Swept Under Carpet
Sleep and circadian rhythm problems linked with poor mental health – new research
Babies use their immune system differently but efficiently
Acquisition Of Gracell Completed
ANU scientists debunk role of ‘junk cells’ in fight against malaria
World-first discovery may enable an effective long-term lupus treatment
Is too much screen time bad for our eyes?
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
WHO’s Science Council issues report on mRNA vaccine technology
Immune protein may induce dementia unrelated to high blood pressure
Resources launched to alleviate increasing shortfall in arthritis care
Funding for Würzburg Biophysicist
Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson’s Disease Patients Worldwide in Japan
Immutep announces the completion of key stage of AIPAC-003 trial in metastatic breast cancer
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Strength in diversity – computing healthy microbiome relationships
Mater clinic keeps young country star singing
New impulses for immune research
On trail of secrets of immune cells
6 common Hodgkin lymphoma questions
Gold in Paris, antibiotic resistance and the start of a science career
Tall Poppy working on a smart solution to heal wounds and prevent scars
Autoimmunity art: Making science accessible for blind and low-vision audiences
AstraZeneca announces agreement with Quell Therapeutics to develop, manufacture and commercialise engineered T-regulatory cell therapies for autoimmune diseases
Long COVID could be caused by the virus lingering in the body. Here’s what the science says
HKUST-Sino One Million Dollar Entrepreneurship Competition 2023
New Monash Spinout Resseptor Therapeutics Launches With AU$2.25M Investment From IP Group
Tackling the rise of autoimmune diseases with genetically modified cell therapies
Engineers building tools to improve quality, production of disease-fighting cells
Maths unlocks molecular interactions that open window to how life evolved
Proto Axiom invests in University of Sydney spin-out, EndoAxiom
Urgent action needed to safeguard workers from engineered stone
Spin-off developing oral insulin receives commercial backing
Immutep announces changes to its board of directors
T cells open door to potential immune therapies
Specialised garbage disposal cell, implicated in autoimmune
Leading scientist ever hopeful for lupus treatment